CBIO — CRESCENT BIOPHARMA INC.
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 87 SEC-registered investment managers reported holding CBIO (CRESCENT BIOPHARMA INC.) in their latest 13F filings, with a combined reported value of $543.15M across 30.45M shares. That is +14.0% by share count (+3.52M shares) versus the previous quarter, while reported value moved +12.0%. Ownership is concentrated: the five largest holders account for 45.3% of reported value and the top ten for 70.3%.
Compared with the prior quarter, 35 opened new positions, 17 added to existing stakes, 16 trimmed, 13 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of CRESCENT BIOPHARMA INC. (CBIO) include Fidelity Management & Research (FMR), BVF INC/IL, Fairmount Funds Management LLC, ranked by reported 13F value among the 151 institutional holders on this page.
CBIO is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 56 | 13.56M | $197.90M | +56.8% |
| Q2 2026 | 87 | 30.45M | $543.15M | +14.0% |
| Q1 2026 | 65 | 26.58M | $482.57M | +8.9% |
| Q4 2025 | 59 | 24.66M | $288.25M | +62.2% |
| Q3 2025 | 42 | 11.72M | $134.80M | -0.2% |
| Q2 2025 | 30 | 10.93M | $176.44M | — |
| Q1 2025 | 1 | 22 | $170 | — |
| Q4 2024 | 1 | 15 | $182 | — |
Over the 8 quarters shown, institutional share counts increased 90426273% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2025 (+62.2%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.90M | $86.15M | 0.00% | Add | |
| 2.14M | $31.20M | 0.00% | Add | |
| 1.27M | $18.51M | 0.00% | Add | |
| 843.07K | $12.30M | 0.00% | Add | |
| 735.09K | $10.73M | 0.00% | Add | |
| 400.00K | $5.84M | 0.14% | New | |
| 372.86K | $5.44M | 2.37% | Hold | |
| 361.25K | $5.27M | 1.93% | Hold | |
| 287.40K | $4.19M | 0.00% | Add | |
| 208.84K | $3.05M | 0.00% | Add | |
| 205.79K | $3.00M | 0.00% | Add | |
| 167.60K | $2.45M | 1.82% | Add | |
| 144.66K | $2.11M | 0.00% | Add | |
| 131.41K | $1.92M | 0.00% | Reduce | |
| 67.83K | $989.58K | 0.00% | Add | |
| 41.17K | $600.74K | 0.00% | Add | |
| 31.14K | $454.40K | 0.00% | Add | |
| 25.17K | $367.25K | 0.00% | Add | |
| 24.93K | $363.76K | 0.14% | Add | |
| 22.49K | $328.16K | 0.00% | Add | |
| 20.98K | $306.14K | 0.00% | New | |
| 20.00K | $291.80K | 0.00% | New | |
| 17.71K | $258.36K | 0.06% | Reduce | |
| 17.62K | $257.15K | 0.00% | Add | |
| 17.02K | $248.25K | 0.00% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 4.13M | $74.40M | 0.00% | Hold | |
| 2.75M | $49.48M | 1.26% | Hold | |
| 2.75M | $49.46M | 3.27% | Hold | |
| 2.13M | $38.40M | 1.16% | Hold | |
| 1.90M | $34.20M | 1.47% | Add | |
| 1.68M | $30.20M | 4.03% | Hold | |
| 1.66M | $29.93M | 0.10% | Add | |
| 1.63M | $29.34M | 0.69% | Add | |
| 1.32M | $23.75M | 2.15% | Add | |
| 1.27M | $22.89M | 0.00% | Add | |
| 1.16M | $20.88M | 0.95% | Hold | |
| 767.75K | $13.82M | 0.00% | Reduce | |
| 453.69K | $8.17M | 0.61% | Hold | |
| 403.86K | $7.27M | 0.00% | Add | |
| 403.86K | $7.27M | 0.01% | Add | |
| 384.58K | $6.92M | 0.00% | New | |
| 384.58K | $6.92M | 0.00% | Add | |
| 378.51K | $6.81M | 0.00% | Add | |
| 372.86K | $6.71M | 3.09% | Hold | |
| 372.86K | $6.71M | 0.06% | Hold | |
| 361.25K | $6.50M | 1.44% | Hold | |
| 302.57K | $5.45M | 0.00% | New | |
| 300.00K | $5.40M | 0.02% | Hold | |
| 275.58K | $4.96M | 0.00% | Reduce | |
| 214.30K | $3.86M | 0.01% | Add |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 4.13M | $75.93M | 0.00% | Hold | |
| 2.75M | $50.49M | 1.61% | Hold | |
| 2.75M | $50.48M | 3.65% | Hold | |
| 2.13M | $39.19M | 1.46% | Hold | |
| 1.68M | $30.82M | 4.27% | Hold | |
| 1.51M | $27.74M | 0.09% | Add | |
| 1.50M | $27.55M | 0.77% | Hold | |
| 1.31M | $24.11M | 3.26% | Add | |
| 1.16M | $21.31M | 1.08% | Add | |
| 801.39K | $14.72M | 0.00% | New | |
| 482.50K | $8.86M | 0.47% | Reduce | |
| 453.69K | $8.33M | 1.09% | Hold | |
| 453.69K | $8.33M | 0.14% | Hold | |
| 372.86K | $6.85M | 3.18% | Hold | |
| 372.86K | $6.85M | 0.07% | Hold | |
| 361.25K | $6.64M | 2.36% | Hold | |
| 323.55K | $5.94M | 0.00% | Add | |
| 323.55K | $5.94M | 0.01% | Add | |
| 303.55K | $5.58M | 0.00% | Reduce | |
| 300.00K | $5.51M | 0.02% | Hold | |
| 264.00K | $4.85M | 0.01% | Hold | |
| 228.47K | $4.20M | 0.00% | Add | |
| 213.63K | $3.92M | 0.01% | Add | |
| 206.94K | $3.80M | 0.08% | Reduce | |
| 200.78K | $3.69M | 0.01% | Add |
Q4 2025 — 25 funds
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.41M | $16.82M | 0.00% | Hold | |
| 1.39M | $16.50M | 1.49% | Hold | |
| 1.39M | $16.50M | 0.93% | Hold | |
| 1.39M | $16.50M | 0.67% | Hold | |
| 679.82K | $8.08M | 0.31% | Add | |
| 657.90K | $7.82M | 0.00% | New | |
| 600.00K | $7.13M | 0.75% | Add | |
| 453.69K | $5.39M | 0.16% | Hold | |
| 453.69K | $5.39M | 1.72% | Hold | |
| 453.69K | $5.39M | 0.15% | Hold | |
| 450.83K | $5.36M | 0.26% | Reduce | |
| 383.60K | $4.56M | 0.00% | New | |
| 302.46K | $3.60M | 0.03% | Hold | |
| 272.95K | $3.25M | 0.10% | Reduce | |
| 200.00K | $2.38M | 0.00% | Add | |
| 200.00K | $2.38M | 0.12% | Reduce | |
| 109.11K | $1.30M | 0.00% | Add | |
| 102.71K | $1.22M | 0.01% | Add | |
| 75.61K | $899.05K | 0.00% | Hold | |
| 69.13K | $822.02K | 0.00% | New | |
| 43.69K | $519.52K | 0.00% | New | |
| 36.98K | $439.63K | 0.00% | New | |
| 28.32K | $336.70K | 0.00% | New | |
| 26.90K | $319.84K | 0.00% | New | |
| 25.59K | $304.30K | 0.00% | New |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.41M | $22.83M | 0.00% | New | |
| 1.39M | $22.40M | 2.90% | New | |
| 1.39M | $22.40M | 1.68% | New | |
| 1.39M | $22.40M | 0.80% | New | |
| 642.72K | $10.37M | 0.44% | New | |
| 553.69K | $8.94M | 1.04% | New | |
| 453.69K | $7.32M | 3.69% | New | |
| 453.69K | $7.32M | 0.52% | New | |
| 453.69K | $7.32M | 0.23% | New | |
| 453.69K | $7.32M | 0.27% | New | |
| 453.69K | $7.32M | 0.29% | New | |
| 400.00K | $6.46M | 0.43% | New | |
| 302.46K | $4.88M | 0.04% | New | |
| 280.03K | $4.52M | 0.70% | New | |
| 261.50K | $4.22M | 0.17% | New | |
| 179.89K | $2.90M | 0.00% | New | |
| 179.89K | $2.90M | 0.00% | New | |
| 100.91K | $1.63M | 0.00% | New | |
| 75.61K | $1.22M | 0.01% | New | |
| 50.15K | $809.45K | 0.04% | New | |
| 27.10K | $437.33K | 0.01% | New | |
| 15.39K | $248.46K | 0.00% | New | |
| 9.23K | $148.99K | 0.00% | New | |
| 6.05K | $97.66K | 0.00% | New | |
| 286 | $4.62K | 0.00% | New |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 384.58K sh · $6.92M
- AMERIPRISE FINANCIAL INC 302.57K sh · $5.45M
- VANGUARD PORTFOLIO MANAGEMENT LLC 188.80K sh · $3.40M
- STEMPOINT CAPITAL LP 182.38K sh · $3.28M
- SECTORAL ASSET MANAGEMENT INC 121.30K sh · $2.18M
- Blackstone Inc. 62.65K sh · $1.13M
- Y-Intercept (Hong Kong) Ltd 50.82K sh · $914.83K
- Charles Schwab Investment Management 50.26K sh · $904.64K
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 50.26K sh · $904.64K
- Sixth Street Partners Management Company, L.P. 50.26K sh · $904.64K
- Nuveen, LLC 47.63K sh · $857.32K
- BNY Mellon 45.78K sh · $824.00K
Fully Exited (vs previous quarter)
- Deep Track Capital, LP sold 453.69K sh · $8.33M
- Alyeska Investment Group, L.P. sold 264.00K sh · $4.85M
- Goldman Sachs Group sold 228.47K sh · $4.20M
- SUSQUEHANNA INTERNATIONAL GROUP, LLP sold 213.63K sh · $3.92M
- Hudson Bay Capital Management LP sold 88.87K sh · $1.63M
- STATE STREET CORP sold 39.07K sh · $717.66K
- Lighthouse Investment Partners, LLC sold 25.00K sh · $459.25K
- Renaissance Technologies sold 24.26K sh · $445.69K
- Brevan Howard Capital Management LP sold 19.53K sh · $358.77K
- OMERS ADMINISTRATION Corp sold 17.80K sh · $326.99K
- ALGERT GLOBAL LLC sold 13.81K sh · $253.62K
- Verdad Advisers, LP sold 12.75K sh · $234.18K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 5.90M | 4.13M | 4.13M | 4.13M | 1.41M | 1.41M | — | — | — | — | — | 1 | — | — | — | — | — |
| BlackRock Inc | 2.14M | 1.27M | 115.72K | 109.23K | 109.11K | 6.05K | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.27M | 767.75K | 801.39K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 843.07K | — | 39.07K | 26.22K | 18.62K | — | — | — | — | 72.60K | — | — | — | — | — | — | — |
| Geode Capital Management | 735.09K | 384.58K | 104.22K | 91.08K | 69.13K | — | — | — | — | 258.75K | 270.03K | 270.03K | 274.59K | 275.26K | 275.26K | 299.20K | 286.58K |
| Siren, L.L.C. | 400.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| NEXTBio Capital Management LP | 372.86K | 372.86K | 372.86K | 372.86K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Remedium Capital Partners, LLC | 361.25K | 361.25K | 361.25K | 361.25K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 287.40K | 188.80K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 208.84K | 75.22K | 49.42K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 205.79K | 175.18K | 82.71K | 7.12K | 12.66K | 223 | — | — | — | 5.08K | 25.98K | — | — | — | 7.68K | — | 5.21K |
| SECTORAL ASSET MANAGEMENT INC | 167.60K | 121.30K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nuveen, LLC | 144.66K | 47.63K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Marshall Wace | 131.41K | 214.30K | 200.78K | 21.83K | 43.69K | — | — | — | — | — | — | — | — | — | — | — | 67.61K |
| BNY Mellon | 67.83K | 45.78K | — | — | — | — | — | — | — | — | — | 200.64K | 200.64K | 202.15K | 202.15K | 216.81K | 75.31K |
| Quadrature Capital Ltd | 41.17K | 19.23K | 20.92K | 13.25K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| RHUMBLINE ADVISERS | 31.14K | 25.49K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Vanguard Global Advisers, LLC | 25.17K | 2.71K | 3.47K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Persistent Asset Partners Ltd | 24.93K | 10.97K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 22.49K | 17.70K | 18.58K | 27.52K | 145 | 15.39K | — | — | — | 97.75K | 76.10K | 38.40K | 36.01K | 36.11K | 36.55K | 62.73K | 514.23K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold CBIO?
As of 2026-Q2, 87 institutional funds reported holding CBIO (CRESCENT BIOPHARMA INC.) in SEC 13F filings, with a combined reported value of $543.15M.
How many shares of CBIO do institutions own?
13F filers reported 30.45M shares of CBIO, worth $543.15M in aggregate at the end of 2026-Q2.
Is institutional ownership of CBIO rising or falling?
Share counts moved +14.0% versus the prior quarter — accumulation.
Who are the top institutional holders of CBIO?
The largest 13F holders are Fidelity Management & Research (FMR), BVF INC/IL, Fairmount Funds Management LLC, Venrock Adviser, LLC, Logos Global Management LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of CRESCENT BIOPHARMA INC.?
The major shareholders of CRESCENT BIOPHARMA INC. (CBIO) by reported 13F value are Fidelity Management & Research (FMR), BVF INC/IL, Fairmount Funds Management LLC, Venrock Adviser, LLC, Logos Global Management LP, among 151 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.